BDBM492259 5-(6-(tert-Butylamino)-4-(difluoromethyl)pyridin-3-yl)-N-((1R,3S)-3-hydroxycyclobutyl)-4-((S)-2-methylpyrrolidine-1-carbonyl)thiazole-2-carboxamide::US10975068, Example 400

SMILES C[C@H]1CCCN1C(=O)c1nc(sc1-c1cnc(NC(C)(C)C)cc1C(F)F)C(=O)N[C@H]1C[C@H](O)C1

InChI Key InChIKey=HVPLTTBYXISSJL-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492259   

TargetNuclear receptor ROR-gamma(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM492259(5-(6-(tert-Butylamino)-4-(difluoromethyl)pyridin-3...)
Affinity DataKd:  13nMAssay Description:1,8-ANS (Invitrogen) was used as a fluorescent dye. Protein and compound solutions are dispensed into black 384-well polypropylene PCR microplates (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2021
Entry Details
US Patent